ApexBio vs Lotus Pharm: monthly revenue

Monthly revenue and year-on-year change for ApexBio (1733) and Lotus Pharm (1795) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ ApexBio ━ Lotus Pharm

0%+226%-24%25/1026/0126/0426/0726/10

Monthly revenue history

MonthApexBioYoYLotus PharmYoY
Oct 2026NT$133.9 million-13.9%NT$2.13 billion-22.5%
Sep 2026NT$139.4 million-23.0%NT$2.77 billion+128.0%
Aug 2026NT$146.4 million-0.4%NT$2.11 billion+81.7%
Jul 2026NT$142.6 million+30.5%NT$2.49 billion+3.9%
Jun 2026NT$174 million+20.1%NT$3.4 billion+225.5%
May 2026NT$145.7 million-18.1%NT$2.32 billion+105.8%
Apr 2026NT$151 million-19.3%NT$3.09 billion+19.9%
Mar 2026NT$141.4 million-24.1%NT$4.35 billion+173.6%
Feb 2026NT$178.3 million-12.0%NT$2.24 billion+131.5%
Jan 2026NT$200.1 million+17.9%NT$2.05 billion-5.5%
Dec 2025NT$143 million-16.1%NT$2.44 billion+66.9%
Nov 2025NT$140.5 million+10.9%NT$1.06 billion-0.2%
Oct 2025NT$155.5 million-0.8%NT$2.75 billion+46.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16